Your browser doesn't support javascript.
loading
Heparan Sulfate Mimetics Accelerate Postinjury Skeletal Muscle Regeneration.
Bouvière, Jessica; Trignol, Aurélie; Hoang, Dieu-Huong; Del Carmine, Peggy; Goriot, Marie-Emmanuelle; Ben Larbi, Sabrina; Barritault, Denis; Banzet, Sébastien; Chazaud, Bénédicte.
Afiliação
  • Bouvière J; Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR-5310, INSERM U-1217, Lyon, France.
  • Trignol A; Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR-5310, INSERM U-1217, Lyon, France.
  • Hoang DH; Département Soutien Médico-Chirurgical des Forces, Institut de Recherche Biomédicale des Armées, UMR-MD-1197, Clamart, France.
  • Del Carmine P; Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR-5310, INSERM U-1217, Lyon, France.
  • Goriot ME; Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR-5310, INSERM U-1217, Lyon, France.
  • Ben Larbi S; Département Soutien Médico-Chirurgical des Forces, Institut de Recherche Biomédicale des Armées, UMR-MD-1197, Clamart, France.
  • Barritault D; Institut NeuroMyoGène, Univ Lyon, Université Claude Bernard Lyon 1, CNRS UMR-5310, INSERM U-1217, Lyon, France.
  • Banzet S; OTR3, Paris, France.
  • Chazaud B; Laboratoire CRRET, Université Paris-Est Creteil, Créteil, France.
Tissue Eng Part A ; 25(23-24): 1667-1676, 2019 12.
Article em En | MEDLINE | ID: mdl-31062647
Although skeletal muscle is capable of complete recovery after an injury, specific situations require support or acceleration of this process, such as in the elderly and athletes, respectively. Skeletal muscle regeneration is due to muscle stem cells (MuSCs) that undergo adult myogenesis, a process sustained by MuSC environment. Although recognized as important, extracellular matrix (ECM) has been overlooked in this process. Matrix-based therapy aims at improving ECM remodeling to support tissue repair. In this context, we investigated the properties of a single injection of the clinical grade glycosaminoglycan mimetics RGTA® (ReGeneraTing Agents) on skeletal muscle regeneration in a context compatible with a clinical application, that is, 3 days after the injury. Our results show that RGTA-treated muscles showed an increase of the number of myonuclei in regenerating myofibers and an increase of the capillarization of the new myofibers. In vitro experiments showed that RGTA directly acts on MuSCs by stimulating their fusion into myotubes and on endothelial cells by stimulating the formation and maturation of vessels in a 3D culture setup. These results indicate that a single administration of RGTA in regenerating muscle stimulated both myogenesis and angiogenesis, thus accelerating skeletal muscle regeneration. Impact Statement Although highly powerful in normal condition, postinjury skeletal muscle regeneration is less efficient in some situations, such as obese, elderly, or resting people. In other context, such as high-performance sport, skeletal muscle regeneration must be shortened but in a way ensuring a full functional recovery. In this context, our results show that a single injection of the clinical grade glycosaminoglycan mimetics RGTA® (ReGeneraTing Agents), in a context compatible with a clinical application, that is, 3 days after the injury, is beneficial for skeletal muscle regeneration, through the stimulation of both myogenesis and angiogenesis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article